Stem cell gel helps repair traumatic brain injuries

Summary:A scientist has developed a gel that stimulates the growth of stem cells to helps damaged brains recover from traumatic injuries.

A scientist has developed a gel that stimulates the growth of stem cells to helps damaged brains recover from traumatic injuries.

Clemson University bioengineering professor Ning Zhang developed the biomaterial hydrogel, which is injected at the site of injury. The gel has the potential to spur the growth of a patient's own neural stem cells, helping to structurally repair the brain injury site.

"We have seen an increase in brain injuries due to combat, but our strategy can also potentially be applied to head injuries caused by car accidents, falls and gunshot wounds," Zhang said in a statement. "These results that we are seeing in adult lab rats are the first of its kind and show a sustained functional recovery in the animal model of TBI (traumatic brain injury). It also represents one of very few in the traumatic brain injury field that attempts structural repair of the lesion cavity using a tissue-engineering approach."

The gel acts as a vehicle for natural and artificial chemicals that can stimulate biological processes at the site of injury. An injury site often has limited blood supply, causing donor cells to fail to grow or stimulate repair; in research done on rats, Zhang was able re-establish full blood supply at the site of brain injury using the gel, opening the gates for donor brain cells to do their work.

Brain injuries are particularly difficult to repair, since swelling must be controlled in so as not to cause damage.

Popular Science explains the problem with current treatments:

So far, treatments have tried to limit this secondary damage by lowering the temperature or relieving the pressure at the site of injury. However, these techniques are often not very effective.

More recently, scientists have considered transplanting donor brain cells into the wound to repair damaged tissue. This method has so far had limited results when treating brain injuries.

Zhang predicts the procedure may be ready for human testing in three years.

This post was originally published on

Topics: Innovation


Andrew Nusca is a former writer-editor for ZDNet and contributor to CNET. He is also the former editor of SmartPlanet, ZDNet's sister site about innovation. He writes about business, technology and design now but used to cover finance, fashion and culture. He was an intern at Money, Men's Vogue, Popular Mechanics and the New York Daily Ne... Full Bio

zdnet_core.socialButton.googleLabel Contact Disclosure

Kick off your day with ZDNet's daily email newsletter. It's the freshest tech news and opinion, served hot. Get it.

Related Stories

The best of ZDNet, delivered

You have been successfully signed up. To sign up for more newsletters or to manage your account, visit the Newsletter Subscription Center.
Subscription failed.